Cabaseril 1mg (40 tabs) Prfizer

121.20

Category:

Description

Cabaseril 1mg (40 tabs) Prfizer

Introducing Cabaseril 1mg, a revolutionary medication brought to you by Prfizer. With its exceptional pharmacological properties and proven effectiveness, Cabaseril 1mg is designed to provide relief and improve the quality of life for individuals suffering from specific medical conditions. This comprehensive product description will guide you through the features, benefits, correct dosage, and precautions associated with Cabaseril 1mg.

Pharmacological Properties

Cabaseril 1mg contains the active ingredient cabergoline, a potent dopamine receptor agonist. This medication acts on the dopamine receptors in the brain, regulating the levels of dopamine, a neurotransmitter responsible for various bodily functions. By stimulating dopamine receptors, Cabaseril 1mg helps restore the balance of dopamine, leading to improved symptoms and overall well-being.

Effects and Benefits

  • Relieves symptoms of hyperprolactinemia: Cabaseril 1mg effectively reduces the excessive production of prolactin hormone, which can cause various complications such as irregular menstrual cycles, infertility, and breast milk production in both men and women.
  • Treats Parkinson’s disease: Cabaseril 1mg has shown remarkable efficacy in managing the symptoms of Parkinson’s disease, including tremors, stiffness, and impaired movement. It helps restore dopamine levels in the brain, improving motor function and overall mobility.
  • Restores sexual function: By normalizing prolactin levels, Cabaseril 1mg can enhance sexual desire and improve sexual function in individuals experiencing sexual dysfunction due to hyperprolactinemia.
  • Reduces the frequency of pituitary tumors: Cabaseril 1mg has been proven effective in shrinking and reducing the size of pituitary tumors, providing relief from associated symptoms and preventing potential complications.

Correct Dosage and Overdose

It is crucial to follow the prescribed dosage and instructions provided by your healthcare professional. The recommended starting dose of Cabaseril 1mg is typically 0.25mg twice a week, gradually increasing to a maintenance dose of 1mg per week. However, individual dosages may vary based on the specific condition being treated. It is important not to exceed the prescribed dosage to avoid potential side effects or overdose.

In case of accidental overdose, seek immediate medical attention. Symptoms of overdose may include nausea, vomiting, hallucinations, and severe dizziness.

Indications and Contraindications

Cabaseril 1mg is indicated for the treatment of hyperprolactinemia, Parkinson’s disease, and pituitary tumors. It is not recommended for use in individuals with a known hypersensitivity to cabergoline or any other ingredients present in the medication.

Caution should be exercised in patients with a history of heart valve disorders, as cabergoline may increase the risk of valve-related complications. Additionally, individuals with uncontrolled hypertension or severe liver or kidney disease should consult their healthcare provider before initiating treatment with Cabaseril 1mg.

Value to the Customer

Cabaseril 1mg offers immense value to customers by providing effective relief from hyperprolactinemia, Parkinson’s disease, and pituitary tumors. By addressing the root cause of these conditions, Cabaseril 1mg not only alleviates symptoms but also improves overall quality of life. With its proven track record and extensive research, Prfizer ensures the highest standards of quality and safety in every tablet of Cabaseril 1mg.

Don’t let medical conditions hinder your well-being. Choose Cabaseril 1mg and experience the transformative effects it can have on your life. Trust Prfizer to deliver excellence in healthcare.

Additional information

Active ingredient

Dostinex

brand

Pfizer Pharma GmbH

Amount of active ingredient

1mg

Pack of packs

1

Packaging

pack

Reviews

There are no reviews yet.

Be the first to review “Cabaseril 1mg (40 tabs) Prfizer”

Your email address will not be published. Required fields are marked *